Luke Snell

14PUBLICATIONS
55CO-AUTHORS
Medical virologyInfectious diseasesInnate immunityHuman impacts of climate change and human adaptationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages.

Suzanne Pickering, Harry Wilson, Enrico Bravo

|Jan 25, 2024
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/Ritonavir.

Luke B Snell, Aimee McGreal-Bellone, Clemency Nye

|Sep 25, 2023
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection.

Jeffrey Seow, Zayed A Shalim, Carl Graham

|Nov 09, 2022
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.

Maria Jose Lista, Helena Winstone, Harry D Wilson

|Nov 03, 2022
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Luke B Snell, Adela Alcolea-Medina, Themoula Charalampous

|Apr 20, 2022
Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in UK NHS hospitals.

James Blackstone, Oliver Stirrup, Fiona Mapp

Pageof 3

Frequent Collaborators

4 joint publications

Katie J Doores

3 joint publications

Gaia Nebbia

3 joint publications

Harry Wilson

3 joint publications

Michael H Malim